USON US Oncology (MM)

/C O R R E C T I O N -- US Oncology, Inc./ In the news release, US Oncology (Nasdaq: USON) to Provide Latest Company Update at JP Morgan Healthcare Conference, issued yesterday, Jan. 6, by US Oncology, Inc. over PR Newswire, we are advised by the company that the third paragraph, first sentence should read "Tuesday, Jan. 13" rather than "Wednesday, Jan. 13" as originally issued inadvertently. Complete, corrected release follows: HOUSTON, Jan. 6 /PRNewswire-FirstCall/ -- US Oncology, Inc. will be one of the presenting companies at the 22nd Annual JP Morgan Healthcare Conference to be held Jan. 12-15, 2004 at the Westin St. Francis Hotel in San Francisco. US Oncology Chief Financial Officer Bruce Broussard will deliver a presentation outlining the company's current operations and financial results, its position in the cancer-care services industry and the impact of recently passed Medicare reform legislation. The 30-minute presentation on Tuesday, Jan. 13 at 11:30 a.m. (PST) will be followed by a question-and-answer session. An electronic copy of the presentation will be available on the Investor Relations section of the US Oncology Web site at http://www.usoncology.com/ following Broussard's session. About US Oncology, Inc. US Oncology, headquartered in Houston, Texas, is America's premier cancer- care services company. The company provides comprehensive services to a network of affiliated practices -- comprising more than 875 affiliated physicians in over 450 sites, including 78 integrated cancer centers -- in 30 states, with the mission of expanding access to and improving the quality of cancer care in local communities. These practices care for approximately 15 percent of the country's new cancer cases each year. DATASOURCE: US Oncology, Inc. CONTACT: Steve Sievert of US Oncology, Inc., +1-832-601-6193, or Web site: http://www.usoncology.com/

Copyright